Andrea Lukes, MD
Gynecology · Durham, NCNPI 1669556718
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $229,749 of the $289,733 with a category attached, or 79.3%. AbbVie accounts for 60.7% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $90,639 and has fallen 91.6% since, to $7,623 in 2025. Among gynecology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 401 payments — averaging $722.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$176K
- Myovant Sciences Inc.$64K
- Sumitomo Pharma America, Inc.$17K
- Pfizer$14K
- Whitehall International Inc$8K
- Alnylam Pharmaceuticals Inc.$4K
- plus $7K from 16 others
Across 634 payments — averaging $2919.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$394K
- Sumitomo Pharma America, Inc.$308K
- Mylan Inc.$267K
- Merck$255K
- Organon$235K
- Bayer$140K
- plus $251K from 11 others
What the payments were for
- Consulting fees$26,6119%
- Speaking & faculty fees$229,74979%
- Travel & lodging$26,3939%
- Food & beverage$6,8092%
- Education$1700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 218 | $175,793 |
| Myovant Sciences Inc. | 51 | $63,833 |
| Sumitomo Pharma America, Inc. | 20 | $17,123 |
| Pfizer | 22 | $13,841 |
| Whitehall International Inc | 2 | $8,000 |
| Alnylam Pharmaceuticals Inc. | 2 | $3,910 |
| Myovant Sciences GmbH | 2 | $3,801 |
| Bayer | 3 | $1,890 |
| Novo Nordisk | 25 | $429 |
| Astellas Pharma US Inc | 6 | $192 |
| Lilly USA, LLC | 10 | $185 |
| Exact Sciences | 7 | $154 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $143 |
| Mayne Pharma Commercial LLC | 6 | $102 |
| Exeltis, USA Inc. | 5 | $85 |
| AMAG Pharmaceuticals, Inc. | 5 | $80 |
| Vertex | 2 | $47 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$289,733 in reported general payments places this provider in the 95th percentile of 90 gynecology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecology in Durham
- Sheila AllisonDurham$376
- Amy StanfieldDurham$210
- Alyse Kelly JonesCharlotte$377K
- Pouruchis BhiwandiwallaRaleigh$158K
- Jerome GardnerRaleigh$99K
- Jennifer OrrMorehead City$19K
- Gwendolyn KnucklesGreenville$9K
- Nathan WilliamsAsheville$8K
- Arthur DizonConcord$6K
- Lisa RobertsRaleigh$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.